Although we observed no associations between DFS and the expression of VMA21 in the subgroups with different disease stages or chemotherapy regimens, the evidence indicated that elevated VMA21 may be a important factor involved in controlling the progression of CRC. Here, VMA21 is linked to colorectal carcinoma.